1. Home
  2. NFG vs KRYS Comparison

NFG vs KRYS Comparison

Compare NFG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Fuel Gas Company

NFG

National Fuel Gas Company

HOLD

Current Price

$82.47

Market Cap

7.3B

Sector

Utilities

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$215.00

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFG
KRYS
Founded
1902
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
6.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NFG
KRYS
Price
$82.47
$215.00
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
$91.20
$214.22
AVG Volume (30 Days)
597.8K
325.5K
Earning Date
11-05-2025
11-03-2025
Dividend Yield
2.60%
N/A
EPS Growth
576.19
275.72
EPS
5.68
6.66
Revenue
$2,277,541,000.00
$373,164,000.00
Revenue This Year
$21.84
$34.33
Revenue Next Year
$13.95
$48.04
P/E Ratio
$14.52
$32.72
Revenue Growth
17.11
54.51
52 Week Low
$59.01
$122.80
52 Week High
$94.13
$221.84

Technical Indicators

Market Signals
Indicator
NFG
KRYS
Relative Strength Index (RSI) 55.84 67.03
Support Level $79.12 $213.24
Resistance Level $81.94 $221.84
Average True Range (ATR) 1.39 6.76
MACD 0.52 0.37
Stochastic Oscillator 94.50 70.51

Price Performance

Historical Comparison
NFG
KRYS

About NFG National Fuel Gas Company

National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: